Model of demand for labor in the urfo pharmaceutical market

The purpose of the study is to comprehensive assessment of the structure of demand for labor in the pharmaceutical market of the URFO to build empirical functions of the demand for labor resources for pharmaceutical specialists with different qualifications.Цель исследования – комплексная оценка структуры спроса на труд на фармацевтическом рынке УрФО для построения эмпирических функций спроса на трудовые ресурсы для фармацевтических специалистов с разной квалификацией

Differential diagnostics of arterial hypertension: classification and terminology aspects

The author discusses issues of arterial hypertension terminology and classification use in everyday clinical practice

Methodological aspects of circadian rhythm type diagnostics in 24-hour blood pressure monitoring Akhmetzyanova E.Kh.

Different methods for determining circadian blood pressure (BP) rhythm type are used, that makes it difficult to compare various authors' data on circadian BP rhythm type prevalence or its disturbances. A modification of circadian BP type diagnostics, based on parallel 24-hour monitoring of systolic, diastolic, and mean dynamic BP, is proposed

Arterial hypertension prevalence in type 2 diabetes patients (Analysis of Bashkortostan Republic State Diabetes Registry data)

Arterial hypertension (AH) prevalence in Type 2 diabetes mellitus (DM) was studied in adult population (aged above 18 years) of Bashkortostan Republic (BR), according to WHO/ISH criteria (1999). The data were taken from the BR State DM Registry (SDMR). AH prevalence (blood pressure at least 140/90 mm Hg) was 70, 1 % (73, 9 % in females, 69, 3 % in males). In women, advanced AH stages were registered more often than in males. There was a weak correlation of female gender and AH in type 2 DM (r=0, 09)

Arterial hypertension prevalence in patients with Type I diabetes mellitus (part 1)

Arterial hypertension (AH) prevalence inpatients with Type I diabetes mellitus (DM) aged after 18 years (by 1999 WHO criterions) in Bashkortostan Republic was studied. Dates of DM State Registry (DMSR) Bashkortostan's Republic were used. AH prevalence in Type I DM is composed among women 52%, among men - 37%. In Type I DM, was observed association women's sex with AH increase

Circadian blood pressure profile and myocardial hypertrophy in patients with renal arterial hypertension

The authors discuss the role of renal arterial hypertension etiology (chronic glomerulonephritis, chronic pyelonephritis) in myocardial hypertrophy development and the association between 24-hour blood pressure monitoring parameters and left ventricular myocardial mass

Analysis of the determinants of labor demand in the pharmaceutical market segment UrFO

The aim of the study – to analysis of the territorial demand for pharmaceutical human resources in the URFO for the qualitative and quantitative characteristics of the need for pharmaceutical competencies in the labor market in pharmacy.Цель исследования – анализ территориального спроса на фармацевтические кадровые ресурсы в УрФО для качественной и количественной характеристики потребности в фармацевтических компетенциях на рынке труда в фармации

The Effects of Telmisartan and Its Combinations on Office Blood Pressure: Results of Prospective Observational Study TAINA

Aim. To evaluate the effectiveness and safety of telmisartan, used in monotherapy or in combination with hydrochlorothiazide or amlodipine, in real clinical practice in patients with diagnosed arterial hypertension who have not reached the target levels of blood pressure (BP).Material and methods. The study was a non-intervention, prospective, multicenter, comparative, observational, epidemiological program, which was carried out in Russian medical institutions. The total patient population in which the prescribed therapy was administered included 1933 people (758 men and 1175 women, mean age 57.0-59.3 years). Participants were followed-up for 12 weeks. The change in office BP was evaluated on the 4th and 12th week.Results. Significant (p<0.001 in all cases) change in office BP compared with the initial data were recorded in all study groups of therapy already at 4 weeks of treatment and became even more pronounced at 12 weeks. In the telmisartan monotherapy group, BP decreased from 155.7±10.7/92.2±7.6 mm Hg to 131.4±12.1/80.8±7.3 mm Hg at the end of the 4th week and to 125.3±7.6/78.2±6.1 mm Hg – at the end of the 12th week. Similarly, after treatment with the combination of telmisartan and hydrochlorothiazide, BP decreased from 162.7±12.6/94.3±7.9 mm Hg to 133.2±12.5/81.6±8.4 mmHg at the end of the 4th week and to 126.0±7.8/78.4±6.7 mm Hg – at the end of the 12th week. In telmisartan/amlodipine group, a decrease in BP also occurred, from 162.5±13.2/94.6±8.6 mm Hg to 132.8±14.5/81.3±7.5 mm Hg on the 4th week and to 125.4±8.7/78.4±5.6 mm Hg at the end of follow up (12 weeks). The proportion of patients who reached the target BP (<140/90 mm Hg) after treatment with telmisartan as monotherapy was 91.7%, after treatment with telmisartan+hydrochlorothiazide – 89.6%, after treatment with telmisartan+amlodipine – 92.8%. Throughout the program, prescribed therapy was well tolerated by patients. During the study, 47 adverse events (AEs) were recorded in 36 patients: 31 AEs with telmisartan monotherapy, 5 AEs with telmisartan/hydrochlorothiazide combination, and 11 AEs with telmisartan/amlodipine combination. Most of the AEs registered during the trial resolved by the end of the study, in four cases the date of AEs resolve is unknown, in two cases, at the time of completion of the study, AEs continued.Conclusion. In the TAINA study a high antihypertensive efficacy and a comparable favorable safety and tolerability profile of telmisartan, used as monotherapy and in combination with hydrochlorothiazide or amlodipine was determined